News
- Author:
- Whitney McKnight
Publish date: September 24, 2025
Parents worried a clinician would not reply upon their own clinical judgement if they had a diagnostic tool.
News
- Author:
- Whitney McKnight
Publish date: March 24, 2025
IMRT and IGRT are now more effective than historical radiation techniques.
News
- Author:
- Whitney McKnight
Publish date: January 6, 2025
The cutting edge of treating solid tumors with cell therapies got notably sharper in 2024.
News
- Author:
- Whitney McKnight
Publish date: June 27, 2024
Patients with HER2-negative early breast cancer receive preoperative standard of care neoadjuvant treatment with or without tecemotide, in new stud...
Article
- Author:
- Whitney McKnight
Publish date: December 1, 2017
Topics include: Recurrent strep throat • Motivational pharmacotherapy for minority patients with depression • Revised Bethesda System thyroid malig...
News
- Author:
- Whitney McKnight
Publish date: August 14, 2017
MIAMI – Researchers close in on a range of ketamine doses that could provide temporary relief for patients with treatment-resistant depression.
News
- Author:
- Whitney McKnight
Publish date: August 14, 2017
MIAMI – Delivering pharmacotherapy in a culturally sensitive way can help improve antidepressant adherence.
News
- Author:
- Whitney McKnight
Publish date: August 8, 2017
Personal photos of real-time continuous glucose monitors posted to online forums dedicated to diabetes management lead to questions about whether i...
News
- Author:
- Whitney McKnight
Publish date: August 7, 2017
Dr. Elinore F. McCance-Katz, a psychiatrist, is an expert in using pharmacotherapy for treating substance use disorders.
News
- Author:
- Whitney McKnight
Publish date: August 7, 2017
A faster cure for all genotypes of the hepatitis C virus with or without liver disease comes to market.
News
- Author:
- Whitney McKnight
Publish date: August 4, 2017
A faster cure for all genotypes of the hepatitis C virus with or without liver disease comes to market.
Video
- Author:
- Whitney McKnight
Publish date: August 4, 2017
Researchers are studying the role autoimmune reactions such as inflammation play in the pathogenesis of schizophrenia, with and without comorbid su...
News
- Author:
- Whitney McKnight
Publish date: July 26, 2017
MIAMI – A second VMAT2 inhibitor may join Ingrezza as a safe and effective treatment for the movement disorder.
News
- Author:
- Whitney McKnight
Publish date: July 17, 2017
MIAMI – A new research paradigm treats every case as an N of 1 that could improve the care of millions.
News
- Author:
- Whitney McKnight
Publish date: July 11, 2017
MIAMI – Should trauma-focused psychotherapy supplant medication for first-line treatment?
